Strong R&B momentum and margin expansion support 2026, but pricing, Medicare, ICT, and financing costs remain constraints.
| Quarter | Q1 FY26 |
|---|---|
| Length | 63 minutes |
| EPS | $3.72 |
| EPS consensus | $3.59 |
| Revenue | $2.4B |
What changed, guidance prior to now, analyst Q&A candor and the case for and against are part of Core.
Other quarters: Q2 FY26 · Q4 FY25 · Q2 FY25
All WTW earnings · Back to WTW overview
Transcript produced by Signals.AI from the company's own earnings call audio. Not personalized investment advice.